Found: 6
Select item for more details and to access through your institution.
Reply to Chao and Lai.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 8, p. 1552, doi. 10.1093/cid/ciab391
- By:
- Publication type:
- Article
A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 3, p. e710, doi. 10.1093/cid/ciab032
- By:
- Publication type:
- Article
2841. A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate (TZD) and Linezolid (LZD) for Treatment of Ventilated Gram-Positive (G+) Nosocomial Pneumonia.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S67, doi. 10.1093/ofid/ofz359.146
- By:
- Publication type:
- Article
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Does moderate renal impairment affect clinical outcomes in complicated intra-abdominal and complicated urinary tract infections? Analysis of two randomized controlled trials with ceftolozane/tazobactam.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article